Bluebird’s first gene therapy gets European fast track

Bluebird’s first gene therapy gets European fast track

Source: 
PM Live
snippet: 

Gene therapy company Bluebird Bio is on course to file its first product later this year, and has just been granted an accelerated review by the European Medicines Agency.